Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 224 entries
Sorted by: Best Match Show Resources per page
The Potential Use of Methotrexate in the Treatment of Cutaneous Leishmaniasis: In Vitro Assays against Sensitive and Meglumine Antimoniate-resistant Strains of .

Iranian journal of parasitology

Mahmoudvand H, Kheirandish F, Mirbadie SR, Kayedi MH, Rezaei Riabi T, Ghasemi AA, Bamorovat M, Sharifi I.
PMID: 28979343
Iran J Parasitol. 2017 Jul-Sep;12(3):339-347.

BACKGROUND: The present study aimed to evaluate the effect of methotrexate (MTX) alone and in combination with meglumine antimoniate (MA, Glucantime) against sensitive and MA-resistant METHODS: The present study was carried out in 2014 in Leishmaniasis Research Center at...

Cite
Mahmoudvand H, Kheirandish F, Mirbadie SR, et al. The Potential Use of Methotrexate in the Treatment of Cutaneous Leishmaniasis: In Vitro Assays against Sensitive and Meglumine Antimoniate-resistant Strains of . Iran J Parasitol. 2017;12(3):339-347
Mahmoudvand, H., Kheirandish, F., Mirbadie, S. R., Kayedi, M. H., Rezaei Riabi, T., Ghasemi, A. A., Bamorovat, M., & Sharifi, I. (2017). The Potential Use of Methotrexate in the Treatment of Cutaneous Leishmaniasis: In Vitro Assays against Sensitive and Meglumine Antimoniate-resistant Strains of . Iranian journal of parasitology, 12(3), 339-347.
Mahmoudvand, Hossein, et al. "The Potential Use of Methotrexate in the Treatment of Cutaneous Leishmaniasis: In Vitro Assays against Sensitive and Meglumine Antimoniate-resistant Strains of ." Iranian journal of parasitology vol. 12,3 (2017): 339-347.
Mahmoudvand H, Kheirandish F, Mirbadie SR, Kayedi MH, Rezaei Riabi T, Ghasemi AA, Bamorovat M, Sharifi I. The Potential Use of Methotrexate in the Treatment of Cutaneous Leishmaniasis: In Vitro Assays against Sensitive and Meglumine Antimoniate-resistant Strains of . Iran J Parasitol. 2017 Jul-Sep;12(3):339-347. PMID: 28979343; PMCID: PMC5623913.
Copy Download .nbib Format: NLM
First Report on Infant Acute Urticaria after Mother's Parenteral Use of Meglumine Antimoniate (Glucantime): A Case Report.

Iranian journal of public health

Mozafari O, Shorofi SA, Yousefi SS.
PMID: 27957467
Iran J Public Health. 2016 Sep;45(9):1217-1219.

Pentavalent antimonials are still the first drug of choice for the treatment of cutaneous leishmaniasis (CL). Like other treatments, they can cause adverse reactions including musculoskeletal pain, gastrointestinal disturbances, and mild to moderate headaches. In this paper, we report...

Cite
Mozafari O, Shorofi SA, Yousefi SS. First Report on Infant Acute Urticaria after Mother's Parenteral Use of Meglumine Antimoniate (Glucantime): A Case Report. Iran J Public Health. 2016;45(9):1217-1219
Mozafari, O., Shorofi, S. A., & Yousefi, S. S. (2016). First Report on Infant Acute Urticaria after Mother's Parenteral Use of Meglumine Antimoniate (Glucantime): A Case Report. Iranian journal of public health, 45(9), 1217-1219.
Mozafari, Omid, et al. "First Report on Infant Acute Urticaria after Mother's Parenteral Use of Meglumine Antimoniate (Glucantime): A Case Report." Iranian journal of public health vol. 45,9 (2016): 1217-1219.
Mozafari O, Shorofi SA, Yousefi SS. First Report on Infant Acute Urticaria after Mother's Parenteral Use of Meglumine Antimoniate (Glucantime): A Case Report. Iran J Public Health. 2016 Sep;45(9):1217-1219. PMID: 27957467; PMCID: PMC5149476.
Copy Download .nbib Format: NLM
Effects of flunixin meglumine on experimental tendon wound healing: A histopathological and mechanical study in rabbits.

Veterinary research forum : an international quarterly journal

Behfar M, Hobbenaghi R, Sarrafzadeh-Rezaei F.
PMID: 25568677
Vet Res Forum. 2013;4(4):233-8.

Tendons are frequently targets of injury in sports and work. Whether nonsteroidal anti-inflammatory drugs (NSAIDs) have beneficial effects on tendon healing is still a matter of debate. This study was conducted to evaluate effects of flunixin meglumine (FM) on...

Cite
Behfar M, Hobbenaghi R, Sarrafzadeh-Rezaei F. Effects of flunixin meglumine on experimental tendon wound healing: A histopathological and mechanical study in rabbits. Vet Res Forum. 2013;4(4):233-8
Behfar, M., Hobbenaghi, R., & Sarrafzadeh-Rezaei, F. (2013). Effects of flunixin meglumine on experimental tendon wound healing: A histopathological and mechanical study in rabbits. Veterinary research forum : an international quarterly journal, 4(4), 233-8.
Behfar, Mehdi, et al. "Effects of flunixin meglumine on experimental tendon wound healing: A histopathological and mechanical study in rabbits." Veterinary research forum : an international quarterly journal vol. 4,4 (2013): 233-8.
Behfar M, Hobbenaghi R, Sarrafzadeh-Rezaei F. Effects of flunixin meglumine on experimental tendon wound healing: A histopathological and mechanical study in rabbits. Vet Res Forum. 2013;4(4):233-8. PMID: 25568677; PMCID: PMC4279621.
Copy Download .nbib Format: NLM
Localized Bullous Eruption Away From Injection Site, Caused by Intramuscular Meglumine Antimoniate Administration.

The Annals of pharmacotherapy

Ben Salem C, Slim R, Fathallah N, Sriha B, Belajouza C.
PMID: 27048189
Ann Pharmacother. 2016 Jun;50(6):517-8. doi: 10.1177/1060028016641131. Epub 2016 Apr 05.

No abstract available.

Cite
Ben Salem C, Slim R, Fathallah N, et al. Localized Bullous Eruption Away From Injection Site, Caused by Intramuscular Meglumine Antimoniate Administration. Ann Pharmacother. 2016;50(6):517-8doi: 10.1177/1060028016641131.
Ben Salem, C., Slim, R., Fathallah, N., Sriha, B., & Belajouza, C. (2016). Localized Bullous Eruption Away From Injection Site, Caused by Intramuscular Meglumine Antimoniate Administration. The Annals of pharmacotherapy, 50(6), 517-8. https://doi.org/10.1177/1060028016641131
Ben Salem, Chaker, et al. "Localized Bullous Eruption Away From Injection Site, Caused by Intramuscular Meglumine Antimoniate Administration." The Annals of pharmacotherapy vol. 50,6 (2016): 517-8. doi: https://doi.org/10.1177/1060028016641131
Ben Salem C, Slim R, Fathallah N, Sriha B, Belajouza C. Localized Bullous Eruption Away From Injection Site, Caused by Intramuscular Meglumine Antimoniate Administration. Ann Pharmacother. 2016 Jun;50(6):517-8. doi: 10.1177/1060028016641131. Epub 2016 Apr 05. PMID: 27048189.
Copy Download .nbib Format: NLM
P-glycoprotein A Gene Expression in Glucantime-Resistant and Sensitive Leishmania major (MRHO/IR/75/ER).

Iranian journal of parasitology

Soleimanifard S, Arjmand R, Saberi S, Khamesipour A, Kazemi M, Salehi M, Akbari M, Hejazi S.
PMID: 25678928
Iran J Parasitol. 2014 Sep;9(3):423-8.

BACKGROUND: Leishmaniasis is a parasitic disease caused by different species of Leishmania parasites with a wide range of clinical manifestations. Antimonial compounds such as meglumine antimoniate (glucantime) are the first line drugs for the treatment of leishmaniasis. However, according...

Cite
Soleimanifard S, Arjmand R, Saberi S, et al. P-glycoprotein A Gene Expression in Glucantime-Resistant and Sensitive Leishmania major (MRHO/IR/75/ER). Iran J Parasitol. 2014;9(3):423-8
Soleimanifard, S., Arjmand, R., Saberi, S., Khamesipour, A., Kazemi, M., Salehi, M., Akbari, M., & Hejazi, S. (2014). P-glycoprotein A Gene Expression in Glucantime-Resistant and Sensitive Leishmania major (MRHO/IR/75/ER). Iranian journal of parasitology, 9(3), 423-8.
Soleimanifard, Simindokht, et al. "P-glycoprotein A Gene Expression in Glucantime-Resistant and Sensitive Leishmania major (MRHO/IR/75/ER)." Iranian journal of parasitology vol. 9,3 (2014): 423-8.
Soleimanifard S, Arjmand R, Saberi S, Khamesipour A, Kazemi M, Salehi M, Akbari M, Hejazi S. P-glycoprotein A Gene Expression in Glucantime-Resistant and Sensitive Leishmania major (MRHO/IR/75/ER). Iran J Parasitol. 2014 Sep;9(3):423-8. PMID: 25678928; PMCID: PMC4316575.
Copy Download .nbib Format: NLM
Comparison of Proteome Profiling of Two Sensitive and Resistant Field Iranian Isolates of Leishmania major to Glucantime® by 2- Dimensional Electrophoresis.

Iranian journal of parasitology

Zarean M, Maraghi S, Hajjaran H, Mohebali M, Feiz-Hadad MH, Assarehzadegan MA.
PMID: 25904942
Iran J Parasitol. 2015 Jan-Mar;10(1):19-29.

BACKGROUND: In this study, two-dimensional gel electrophoresis (2-DE) method was applied to determine and compare the protein spots expressed in the two field isolates of Leishmania major and recovered from the patients who were clinically sensitive and resistant to...

Cite
Zarean M, Maraghi S, Hajjaran H, et al. Comparison of Proteome Profiling of Two Sensitive and Resistant Field Iranian Isolates of Leishmania major to Glucantime® by 2- Dimensional Electrophoresis. Iran J Parasitol. 2015;10(1):19-29
Zarean, M., Maraghi, S., Hajjaran, H., Mohebali, M., Feiz-Hadad, M. H., & Assarehzadegan, M. A. (2015). Comparison of Proteome Profiling of Two Sensitive and Resistant Field Iranian Isolates of Leishmania major to Glucantime® by 2- Dimensional Electrophoresis. Iranian journal of parasitology, 10(1), 19-29.
Zarean, Mehdi, et al. "Comparison of Proteome Profiling of Two Sensitive and Resistant Field Iranian Isolates of Leishmania major to Glucantime® by 2- Dimensional Electrophoresis." Iranian journal of parasitology vol. 10,1 (2015): 19-29.
Zarean M, Maraghi S, Hajjaran H, Mohebali M, Feiz-Hadad MH, Assarehzadegan MA. Comparison of Proteome Profiling of Two Sensitive and Resistant Field Iranian Isolates of Leishmania major to Glucantime® by 2- Dimensional Electrophoresis. Iran J Parasitol. 2015 Jan-Mar;10(1):19-29. PMID: 25904942; PMCID: PMC4403536.
Copy Download .nbib Format: NLM
Nephrotoxicity in dogs associated with methoxyflurane anesthesia and flunixin meglumine analgesia.

The Canadian veterinary journal = La revue veterinaire canadienne

Mathews KA, Doherty T, Dyson DH, Wilcock B, Valliant A.
PMID: 17423691
Can Vet J. 1990 Nov;31(11):766-71.

Uremia unexpectedly developed in five dogs 24 hours after undergoing thoracotomy in a student laboratory. In all dogs general anesthesia had been maintained with methoxyflurane, muscle relaxation had been induced with gallamine, and each dog received a single intravenous...

Cite
Mathews KA, Doherty T, Dyson DH, et al. Nephrotoxicity in dogs associated with methoxyflurane anesthesia and flunixin meglumine analgesia. Can Vet J. 1990;31(11):766-71
Mathews, K. A., Doherty, T., Dyson, D. H., Wilcock, B., & Valliant, A. (1990). Nephrotoxicity in dogs associated with methoxyflurane anesthesia and flunixin meglumine analgesia. The Canadian veterinary journal = La revue veterinaire canadienne, 31(11), 766-71.
Mathews, K A, et al. "Nephrotoxicity in dogs associated with methoxyflurane anesthesia and flunixin meglumine analgesia." The Canadian veterinary journal = La revue veterinaire canadienne vol. 31,11 (1990): 766-71.
Mathews KA, Doherty T, Dyson DH, Wilcock B, Valliant A. Nephrotoxicity in dogs associated with methoxyflurane anesthesia and flunixin meglumine analgesia. Can Vet J. 1990 Nov;31(11):766-71. PMID: 17423691; PMCID: PMC1480876.
Copy Download .nbib Format: NLM
Comparison of oral zinc sulfate with systemic meglumine antimoniate in the treatment of cutaneous leishmaniasis.

Dermatology research and practice

Yazdanpanah MJ, Banihashemi M, Pezeshkpoor F, Khajedaluee M, Famili S, Tavakoli Rodi I, Yousefzadeh H.
PMID: 21747837
Dermatol Res Pract. 2011;2011:269515. doi: 10.1155/2011/269515. Epub 2011 Jul 06.

The purpose of this study was to investigate comparison between oral zinc sulfate and meglumine antimoniate in the treatment of cutaneous leishmaniasis (CL). So 100 patients with CL were included and randomly divided into two groups. The first group...

Cite
Yazdanpanah MJ, Banihashemi M, Pezeshkpoor F, et al. Comparison of oral zinc sulfate with systemic meglumine antimoniate in the treatment of cutaneous leishmaniasis. Dermatol Res Pract. 2011;2011:269515doi: 10.1155/2011/269515.
Yazdanpanah, M. J., Banihashemi, M., Pezeshkpoor, F., Khajedaluee, M., Famili, S., Tavakoli Rodi, I., & Yousefzadeh, H. (2011). Comparison of oral zinc sulfate with systemic meglumine antimoniate in the treatment of cutaneous leishmaniasis. Dermatology research and practice, 2011269515. https://doi.org/10.1155/2011/269515
Yazdanpanah, Mohamad Javad, et al. "Comparison of oral zinc sulfate with systemic meglumine antimoniate in the treatment of cutaneous leishmaniasis." Dermatology research and practice vol. 2011 (2011): 269515. doi: https://doi.org/10.1155/2011/269515
Yazdanpanah MJ, Banihashemi M, Pezeshkpoor F, Khajedaluee M, Famili S, Tavakoli Rodi I, Yousefzadeh H. Comparison of oral zinc sulfate with systemic meglumine antimoniate in the treatment of cutaneous leishmaniasis. Dermatol Res Pract. 2011;2011:269515. doi: 10.1155/2011/269515. Epub 2011 Jul 06. PMID: 21747837; PMCID: PMC3130957.
Copy Download .nbib Format: NLM
Treatment of cutaneous lesion of 20 years' duration caused by leishmanization.

Indian journal of dermatology

Khamesipour A, Abbasi A, Firooz A, Mohammadi AM, Eskandari SE, Jaafari MR.
PMID: 22615509
Indian J Dermatol. 2012 Mar;57(2):123-5. doi: 10.4103/0019-5154.94280.

The inoculation of live Leishmania (L.) major to produce a single lesion is called leishmanization (LZ). LZ lesion upon cure prevents further natural infection which might be multiple lesions on unwanted sites such as face. Cutaneous leishmaniasis (CL) usually...

Cite
Khamesipour A, Abbasi A, Firooz A, et al. Treatment of cutaneous lesion of 20 years' duration caused by leishmanization. Indian J Dermatol. 2012;57(2):123-5doi: 10.4103/0019-5154.94280.
Khamesipour, A., Abbasi, A., Firooz, A., Mohammadi, A. M., Eskandari, S. E., & Jaafari, M. R. (2012). Treatment of cutaneous lesion of 20 years' duration caused by leishmanization. Indian journal of dermatology, 57(2), 123-5. https://doi.org/10.4103/0019-5154.94280
Khamesipour, Ali, et al. "Treatment of cutaneous lesion of 20 years' duration caused by leishmanization." Indian journal of dermatology vol. 57,2 (2012): 123-5. doi: https://doi.org/10.4103/0019-5154.94280
Khamesipour A, Abbasi A, Firooz A, Mohammadi AM, Eskandari SE, Jaafari MR. Treatment of cutaneous lesion of 20 years' duration caused by leishmanization. Indian J Dermatol. 2012 Mar;57(2):123-5. doi: 10.4103/0019-5154.94280. PMID: 22615509; PMCID: PMC3352634.
Copy Download .nbib Format: NLM
Antileishmanial Activity of .

Iranian journal of parasitology

Shokri A, Saeedi M, Fakhar M, Morteza-Semnani K, Keighobadi M, Hosseini Teshnizi S, Kelidari HR, Sadjadi S.
PMID: 29317888
Iran J Parasitol. 2017 Oct-Dec;12(4):622-631.

BACKGROUND: The aim of present study was to evaluate antileishmanial effects of METHODS: The present study was performed in Leishmaniasis Reference Lab at Mazandaran University of Medical Sciences, Iran during 2016-2017. The IC50 values were calculated in both the...

Cite
Shokri A, Saeedi M, Fakhar M, et al. Antileishmanial Activity of . Iran J Parasitol. 2017;12(4):622-631
Shokri, A., Saeedi, M., Fakhar, M., Morteza-Semnani, K., Keighobadi, M., Hosseini Teshnizi, S., Kelidari, H. R., & Sadjadi, S. (2017). Antileishmanial Activity of . Iranian journal of parasitology, 12(4), 622-631.
Shokri, Azar, et al. "Antileishmanial Activity of ." Iranian journal of parasitology vol. 12,4 (2017): 622-631.
Shokri A, Saeedi M, Fakhar M, Morteza-Semnani K, Keighobadi M, Hosseini Teshnizi S, Kelidari HR, Sadjadi S. Antileishmanial Activity of . Iran J Parasitol. 2017 Oct-Dec;12(4):622-631. PMID: 29317888; PMCID: PMC5756313.
Copy Download .nbib Format: NLM
Spectrophotometric Methods for Simultaneous Determination of Oxytetracycline HCl and Flunixin Meglumine in Their Veterinary Pharmaceutical Formulation.

Journal of analytical methods in chemistry

Merey HA, Abd-Elmonem MS, Nazlawy HN, Zaazaa HE.
PMID: 28811956
J Anal Methods Chem. 2017;2017:2321572. doi: 10.1155/2017/2321572. Epub 2017 Jul 24.

Four precise, accurate, selective, and sensitive UV-spectrophotometric methods were developed and validated for the simultaneous determination of a binary mixture of Oxytetracycline HCl (OXY) and Flunixin Meglumine (FLU). The first method, dual wavelength (DW), depends on measuring the difference...

Cite
Merey HA, Abd-Elmonem MS, Nazlawy HN, et al. Spectrophotometric Methods for Simultaneous Determination of Oxytetracycline HCl and Flunixin Meglumine in Their Veterinary Pharmaceutical Formulation. J Anal Methods Chem. 2017;2017:2321572doi: 10.1155/2017/2321572.
Merey, H. A., Abd-Elmonem, M. S., Nazlawy, H. N., & Zaazaa, H. E. (2017). Spectrophotometric Methods for Simultaneous Determination of Oxytetracycline HCl and Flunixin Meglumine in Their Veterinary Pharmaceutical Formulation. Journal of analytical methods in chemistry, 20172321572. https://doi.org/10.1155/2017/2321572
Merey, Hanan A, et al. "Spectrophotometric Methods for Simultaneous Determination of Oxytetracycline HCl and Flunixin Meglumine in Their Veterinary Pharmaceutical Formulation." Journal of analytical methods in chemistry vol. 2017 (2017): 2321572. doi: https://doi.org/10.1155/2017/2321572
Merey HA, Abd-Elmonem MS, Nazlawy HN, Zaazaa HE. Spectrophotometric Methods for Simultaneous Determination of Oxytetracycline HCl and Flunixin Meglumine in Their Veterinary Pharmaceutical Formulation. J Anal Methods Chem. 2017;2017:2321572. doi: 10.1155/2017/2321572. Epub 2017 Jul 24. PMID: 28811956; PMCID: PMC5546081.
Copy Download .nbib Format: NLM
Anti-Leishmanial and Immunomodulatory Effects of Epigallocatechin 3-O-Gallate on .

Iranian journal of parasitology

Saduqi M, Sharifi I, Babaei Z, Keyhani A, Mostafavi M, Hakimi Parizi M, Ghasemian M, Bamorovat M, Sharifi F, Aflatoonian MR, Sharififar F, Ghasemi Nejad P, Khosravi A, Salarkia E, Varma RS.
PMID: 32099555
Iran J Parasitol. 2019 Oct-Dec;14(4):521-533.

BACKGROUND: Pentavalent antimonials such as meglumine antimoniate (MA, Glucantime), are the first-line treatment against leishmaniasis, but at present, they have basically lost their efficacy. This study was aimed to explore epigallocatechin 3-O-gallate (EGCG), alone or in combination with MA...

Cite
Saduqi M, Sharifi I, Babaei Z, et al. Anti-Leishmanial and Immunomodulatory Effects of Epigallocatechin 3-O-Gallate on . Iran J Parasitol. 2019;14(4):521-533
Saduqi, M., Sharifi, I., Babaei, Z., Keyhani, A., Mostafavi, M., Hakimi Parizi, M., Ghasemian, M., Bamorovat, M., Sharifi, F., Aflatoonian, M. R., Sharififar, F., Ghasemi Nejad, P., Khosravi, A., Salarkia, E., & Varma, R. S. (2019). Anti-Leishmanial and Immunomodulatory Effects of Epigallocatechin 3-O-Gallate on . Iranian journal of parasitology, 14(4), 521-533.
Saduqi, Morteza, et al. "Anti-Leishmanial and Immunomodulatory Effects of Epigallocatechin 3-O-Gallate on ." Iranian journal of parasitology vol. 14,4 (2019): 521-533.
Saduqi M, Sharifi I, Babaei Z, Keyhani A, Mostafavi M, Hakimi Parizi M, Ghasemian M, Bamorovat M, Sharifi F, Aflatoonian MR, Sharififar F, Ghasemi Nejad P, Khosravi A, Salarkia E, Varma RS. Anti-Leishmanial and Immunomodulatory Effects of Epigallocatechin 3-O-Gallate on . Iran J Parasitol. 2019 Oct-Dec;14(4):521-533. PMID: 32099555; PMCID: PMC7028242.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 224 entries